Humanized and affinity matured antibodies to FcRH5 and methods of use
US12030947B2 · kind B2 · utility
0Cited by
52References
70Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 29, 2021 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | Dec 29, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70535
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-FcRH5 antibodies, including anti-FcRH5 antibodies comprising an FcRH5 binding domain and a CD3 binding domain (e.g., FcRH5 T cell-dependent bispecific (TDB) antibodies), and methods of using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.